CARDINAL HEALTH INC
For the period ended Sep 30, 2024. Filed Nov 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
| Period | Total Numberof SharesPurchased (1) | Average Price Paid per Share(2) | Total Number of SharesPurchasedas Part of Publicly Announced Programs (2,3) | ApproximateDollar Value ofShares That MayYet be PurchasedUnder the Program (3)(in millions) |
|---|---|---|---|---|
| July 2024 | 143 | $95.46 | — | $3,493 |
| Aug 2024 | 2,736,169 | 109.65 | 2,735,978 | 3,193 |
| Sept 2024 | 723 | 111.72 | — | 3,193 |
| Total | 2,737,035 | $109.65 | 2,735,978 | $3,193 |
(1)Reflects 143, 191 and 723 common shares purchased in July, August, and September 2024, respectively, through a rabbi trust as investments of participants in our Deferred Compensation Plan.
(2)On August 21, 2024, we entered into an ASR program to purchase common shares for an aggregate purchase price of $375 million and received an initial delivery of 2.7 million common shares using a reference price of $109.65. The ASR program concluded on October 30, 2024 at a volume weighted average price per common share of $110.10 resulting in a final delivery of 0.7 million common shares. See Note 11 of the "Notes to Condensed Consolidated Financial Statements" for additional information.
(3)On June 7, 2023, our Board of Directors approved a new $3.5 billion share repurchase program, which will expire on December 31, 2027. As of September 30, 2024, we had $3.2 billion authorized for share repurchases remaining under this program.
| 19 | Cardinal Health | Q1 Fiscal 2025 Form 10-Q |
Other
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.